Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
Bárcena C, Stefanovic M, Tutusaus A, Joannas L, Menéndez A, García-Ruiz C, Sancho-Bru P, Marí M, Caballeria J, Rothlin CV, Fernández-Checa JC, de Frutos PG, Morales A. Bárcena C, et al. Among authors: stefanovic m. J Hepatol. 2015 Sep;63(3):670-8. doi: 10.1016/j.jhep.2015.04.013. Epub 2015 Apr 20. J Hepatol. 2015. PMID: 25908269 Free PMC article.
Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma.
Tutusaus A, Stefanovic M, Boix L, Cucarull B, Zamora A, Blasco L, de Frutos PG, Reig M, Fernandez-Checa JC, Marí M, Colell A, Bruix J, Morales A. Tutusaus A, et al. Among authors: stefanovic m. Oncotarget. 2018 Mar 30;9(24):16701-16717. doi: 10.18632/oncotarget.24673. eCollection 2018 Mar 30. Oncotarget. 2018. PMID: 29682179 Free PMC article.
Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.
Piulats JM, Vidal A, García-Rodríguez FJ, Muñoz C, Nadal M, Moutinho C, Martínez-Iniesta M, Mora J, Figueras A, Guinó E, Padullés L, Aytés À, Molleví DG, Puertas S, Martínez-Fernández C, Castillo W, Juliachs M, Moreno V, Muñoz P, Stefanovic M, Pujana MA, Condom E, Esteller M, Germà JR, Capella G, Farré L, Morales A, Viñals F, García-Del-Muro X, Cerón J, Villanueva A. Piulats JM, et al. Among authors: stefanovic m. Clin Cancer Res. 2018 Aug 1;24(15):3755-3766. doi: 10.1158/1078-0432.CCR-17-1898. Epub 2018 Apr 4. Clin Cancer Res. 2018. PMID: 29618620
Long-term outcomes of spinal SBRT. Is it important to select the treatment time?
Pérez-Montero H, Godino O, Lozano A, Asiáin L, Martínez I, Sánchez JJ, de BlasFernández R, Fernández E, Stefanovic M, García N, Martínez J, Guedea F, Navarro-Martin A. Pérez-Montero H, et al. Among authors: stefanovic m. Clin Transl Oncol. 2022 Feb;24(2):276-287. doi: 10.1007/s12094-021-02684-9. Epub 2021 Aug 3. Clin Transl Oncol. 2022. PMID: 34342817
Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
Stefanovic M, Calvet G, Pérez-Montero H, Esteve A, Bujalance MV, Navarro-Martín A, Fernández MDA, González FF, Borras SM, Borbalas AL, Fernandez MN, Garau MM, Calduch AL, Edo FG. Stefanovic M, et al. Clin Transl Oncol. 2023 Jan;25(1):199-206. doi: 10.1007/s12094-022-02923-7. Epub 2022 Sep 6. Clin Transl Oncol. 2023. PMID: 36068449
Increase in the number of adjuvant radiotherapy treatments in breast cancer patients in 2022: effect of COVID-19 pandemic?
Pérez EM, Montero HP, Viguera JG, Peñacoba MA, Fernández MN, Stefanovic M, Torres ML, Fernández MDA, Borràs SMI, Montells S, Garau MMI. Pérez EM, et al. Among authors: stefanovic m. Clin Transl Oncol. 2023 Dec;25(12):3565-3566. doi: 10.1007/s12094-023-03201-w. Epub 2023 May 9. Clin Transl Oncol. 2023. PMID: 37160572 Free PMC article. No abstract available.
208 results